Schrodinger, Inc. - Common Stock (NQ:SDGR)

32.29 +1.98 (+6.53%)

Delayed Quote Updated: 11:22 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Schrödinger to Present at Jefferies 13th Annual London Healthcare Conference

November 07, 2022

From Schrödinger

Via Business Wire

Yelp, Twilio, Atlassian, And Other Big Losers From Friday ↗

November 07, 2022

U.S. stocks closed higher on Friday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

3 Hypergrowth Stocks That Will Make You a Millionaire by 2027 ↗

November 04, 2022

These companies' great third-quarter results, along with their very promising technologies, are likely to turn them into hypergrowth stocks.

Via InvestorPlace

Schrödinger Reports Third Quarter 2022 Financial Results

November 03, 2022

From Schrödinger, Inc.

Via Business Wire

Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday ↗

November 07, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

November 04, 2022

Friday's session saw 236 companies set new 52-week lows.

Via Benzinga

Schrödinger To Present New Preclinical Data From Its CDC7 Inhibitor Program At American Society Of Hematology 2022 Annual Meeting

November 03, 2022

From Schrödinger, Inc.

Via Business Wire

Schrödinger to Announce Third Quarter 2022 Financial Results on November 3

October 20, 2022

From Schrödinger

Via Business Wire

Schrödinger Hosts Platform Day

October 06, 2022

From Schrödinger

Via Business Wire

Schrödinger to Host Platform Day on October 6, 2022

September 20, 2022

From Schrödinger, Inc.

Via Business Wire

Earnings Scheduled For November 3, 2022 ↗

November 03, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

Via Benzinga

7 Small-Cap Stock Picks to Beat the September Market Slump ↗

September 15, 2022

With the macro environment not as dreary as the bears believe, investors should consider buying one or more of my small-cap stock picks.

Via InvestorPlace

Schrödinger to Present at Citi’s 17th Annual BioPharma Conference

August 31, 2022

From Schrödinger, Inc.

Via Business Wire

Cathie Wood Loads Up $4.6M In Bill Gates-Backed Healthcare Tech Company ↗

August 19, 2022

Cathie Wood-led Ark Investment Management on Thursday bought 162,276 shares of Schrodinger Inc (NASDAQ: SDGR) through the Ark Genomic Revolution ETF (BATS: ARKG), trading d

Via Benzinga

Schrödinger Reports Inducement Grants To Newly Appointed Chief Financial Officer

August 18, 2022

From Schrödinger, Inc.

Via Business Wire

Schrödinger Appoints Geoffrey Porges as Chief Financial Officer

August 18, 2022

From Schrödinger, Inc.

Via Business Wire

Gain Therapeutics: Reasons For Optimism ↗

August 09, 2022

In biotechnology, potential rules. And in Gain's case, the potential to not just treat but functionally cure at least some forms of Parkinson's Disease is strong enough to weather early-stage...

Via Talk Markets

Schrödinger Reports Second Quarter 2022 Financial Results

August 04, 2022

From Schrödinger, Inc.

Via Business Wire

Schrödinger to Announce Second Quarter 2022 Financial Results on August 4

July 21, 2022

From Schrödinger

Via Business Wire

3 Biotech Stocks to Buy on the Dip ↗

July 21, 2022

Biotech stocks have rebounded lately and are poised to keep surging, so it's a good time to buy biotech stocks on the dip.

Via InvestorPlace

The 7 Best Stocks to Buy on a Dip in July ↗

July 14, 2022

With the stock market pricing in a recession that likely won't arrive anytime soon, these are some of the best stocks to buy on a dip.

Via InvestorPlace

Schrödinger's Initial-Stage Cancer Study Gains FDA Clearance ↗

June 28, 2022

Schrödinger Inc. (NASDAQ: SDGR) announced that the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug candidate SGR-1505 in patients with...

Via Benzinga

Schrödinger Announces FDA Clearance of Investigational New Drug Application for SGR-1505, a MALT1 Inhibitor

June 28, 2022

From Schrödinger, Inc.

Via Business Wire

Schrödinger Convenes Global Educators For Second Annual Educator’s Day

June 22, 2022

From Schrödinger, Inc.

Via Business Wire

Bill Gates Stocks: 7 Top Picks From the Gates Foundation Portfolio ↗

June 13, 2022

These Bill Gates stocks are great picks to buy now. BRK-B, CNI, DE, ECL, MSFT, SDGR, and WM can make excellent long-term investments.

Via InvestorPlace

Schrödinger to Present at Jefferies Healthcare Conference

June 02, 2022

From Schrödinger, Inc.

Via Business Wire

Schrödinger Announces Appointment of Arun Oberoi to Board of Directors

May 19, 2022

From Schrödinger, Inc.

Via Business Wire

Schrödinger to Present at Citi Biotech Virtual Co-Panel Day

May 13, 2022

From Schrödinger, Inc.

Via Business Wire

Recap: Schrodinger Q1 Earnings ↗

May 04, 2022

Schrodinger (NASDAQ:SDGR) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Schrodinger beat estimated earnings...

Via Benzinga

Schrödinger Reports First Quarter 2022 Financial Results

May 04, 2022

From Schrödinger, Inc.

Via Business Wire

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.